These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 65753)

  • 1. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man.
    Shillitoe EJ; Tarro G; Lehner T
    Oncology; 1976; 33(4):192-5. PubMed ID: 65753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of oral leukoplakia.
    Lehner T
    Br J Cancer; 1970 Sep; 24(3):442-6. PubMed ID: 4319938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
    Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
    J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
    Sprecher-Golberger S; Thiry L; de Halleux F; Bossens M; Gould I
    Biomedicine; 1975 Nov; 23(9):399-401. PubMed ID: 182294
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immunity and antibodies to Herpesvirus hominis type 1 in oral leukoplakia and carcinoma.
    Lehner T; Wilton JM; Shillitoe EJ; Ivanyi L
    Br J Cancer; 1973 May; 27(5):351-61. PubMed ID: 4351511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
    Russell AS; Kaiser J; Lao VS
    J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell mediated immunity to herpesvirus type 1 in carcinoma and pre-cancerous lesions.
    Lehner T; Shillitoe EJ; Wilton JM; Ivanyi L
    Br J Cancer Suppl; 1973 Aug; 1():128-34. PubMed ID: 4374226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
    Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
    Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.
    Thong YH; Vincent MM; Hensen SA; Fuccillo DA; Rola-Pleszczynski M; Bellanti JA
    Infect Immun; 1975 Jul; 12(1):76-80. PubMed ID: 166930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on an immunoenzymatic assay for herpes simplex virus tumor-associated antigen.
    Tarro G; Flaminio G; Maturo S; Esposito C; Cocchiara R
    Clin Immunol Immunopathol; 1982 Oct; 25(1):126-32. PubMed ID: 6295672
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell response to Herpes simplex virus antigen in vitro.
    Berle EJ; Thorsby E
    Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):31-7. PubMed ID: 6246714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.
    Sabin AB; Tarro G
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3225-9. PubMed ID: 4361685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique immunobiological aspects of head and neck squamous carcinoma.
    Chretien PB
    Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera.
    Eberle R; Mou SW
    J Infect Dis; 1983 Sep; 148(3):436-44. PubMed ID: 6311910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Possible prevention of bronchial carcinoma by recurrent Herpes simplex.
    Ross CA; Tyrrell WF
    Lancet; 1974 May; 1(7862):871. PubMed ID: 4132827
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of the nature of herpesvirus-induced tumour-associated antigens induced by herpes simplex virus type 1 and further analysis of their relationship with squamous-cell carcinomas of the head and neck region.
    Hollinshead AC; Chretien PB; Tarpley JL
    IARC Sci Publ (1971); 1975; (11 Pt 2):307-11. PubMed ID: 191376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.